Phathom Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.About PHAT
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
PHAT Key Statistics
Stock Snapshot
The current Phathom Pharmaceuticals(PHAT) stock price is $14.16, with a market capitalization of 1.13B. The stock trades at a price-to-earnings (P/E) ratio of -3.79.
As of 2026-01-12, Phathom Pharmaceuticals(PHAT) stock has fluctuated between $13.79 and $15.01. The current price stands at $14.16, placing the stock +2.7% above today's low and -5.6% off the high.
The Phathom Pharmaceuticals(PHAT)'s current trading volume is 2.21M, compared to an average daily volume of 1.51M.
During the past year, Phathom Pharmaceuticals(PHAT) stock moved between $2.21 at its lowest and $18.31 at its peak.
During the past year, Phathom Pharmaceuticals(PHAT) stock moved between $2.21 at its lowest and $18.31 at its peak.
PHAT News
U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Thursday. Shares of Immuneering Corp (NASDAQ:IMRX) fell sharpl...
Phathom Pharmaceuticals (PHAT) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu of co...